Phase I study of humanised antibody A33 (Hua33) in patients with colorectal carcinoma - Preliminary whole body clearance and tumour dosimetry: Short title: Dosimetric analysis of [I-131]huA33

A. Hanna, P. U, A. Wallace, P. Schleyer, F. T. Lee, R. Jones, W. Hopkins, D. MacGregor, J. Cebon, A. Rigopoulos, D. Thomas, W. J. McKay, S. Welt, E. Richards, K. S. Kolbert, G. Sgouros, L. Old, A. W. Burgess, A. M. Scott

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Phase I study of humanised antibody A33 (Hua33) in patients with colorectal carcinoma - Preliminary whole body clearance and tumour dosimetry: Short title: Dosimetric analysis of [I-131]huA33'. Together they form a unique fingerprint.